Literature DB >> 23801055

Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass.

Stefan Stättner1, Vincent Yip, Robert P Jones, Carmen Lacasia, Stephen W Fenwick, Graeme J Poston, Hassan Malik.   

Abstract

PURPOSE: Liver resection offers the chance of a cure for liver cancer. However, when extended hepatectomies were performed in combination with resection of the inferior vena cava (IVC), the procedures were reported to have a surgical mortality rate in excess of 5 %. While most of these operations were performed with the use of veno-venous bypass, this study presents our experience performing the procedure without the bypass.
METHODS: Data were collected from a prospectively maintained database. A retrospective evaluation of a consecutive series of concomitant IVC and liver resections was performed.
RESULTS: Five hundred and seventy-five liver resections were performed between June 2008 and November 2011. Eleven patients (1.9 %) underwent concomitant IVC and liver resections. One patient required segmental IVC replacement, and four IVC defects were closed using a bovine pericardial patch without bypass. Only one patient had histologically confirmed IVC invasion. There was no postoperative mortality. Nine postoperative complications occurred in five patients. No complications in terms of IVC patency were seen. Five patients had disease recurrence, one of whom died within 12 months of surgery.
CONCLUSION: Concomitant liver and IVC resection is safe without using a bypass procedure, with acceptable short-term results. Meticulous technique, careful patient selection and a specialized anesthetic team are key to obtaining low postoperative morbidity and mortality rates and an acceptable oncological outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23801055     DOI: 10.1007/s00595-013-0652-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  49 in total

1.  Aggressive liver resection including major-vessel resection for colorectal liver metastases.

Authors:  Kuniya Tanaka; Ryusei Matsuyama; Kazuhisa Takeda; Kenichi Matsuo; Yasuhiko Nagano; Itaru Endo
Journal:  World J Hepatol       Date:  2009-10-31

2.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

3.  Inferior vena cava resection with hepatectomy: challenging but justified.

Authors:  Deep J Malde; Aamir Khan; K Rajendra Prasad; Giles J Toogood; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2011-09-16       Impact factor: 3.647

4.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

5.  Ante-situm liver resection in recurrent liver metastasis from colorectal cancer.

Authors:  Zisun Kim; Gui-Ae Jeong; Jun-Cheol Chung; Chong-Woo Chu; Eung-Jin Shin; Hyung-Chul Kim
Journal:  Hepatogastroenterology       Date:  2009 Mar-Apr

6.  'Close shave' in liver resection for colorectal liver metastases.

Authors:  J T Lordan; N D Karanjia
Journal:  Eur J Surg Oncol       Date:  2009-06-06       Impact factor: 4.424

Review 7.  Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment.

Authors:  Maartje A J van den Broek; Steven W M Olde Damink; Cornelis H C Dejong; Hauke Lang; Massimo Malagó; Rajiv Jalan; Fuat H Saner
Journal:  Liver Int       Date:  2008-07       Impact factor: 5.828

Review 8.  Operative mortality after hepatic resection: are literature-based rates broadly applicable?

Authors:  Bolanle Asiyanbola; David Chang; Ana Luiza Gleisner; Hari Nathan; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-02-12       Impact factor: 3.452

Review 9.  Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome.

Authors:  Jesús García-Foncillas; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.340

10.  Improving surgical outcomes: it is the destination not the journey.

Authors:  Jonathan Wilson; Simon Davies
Journal:  Crit Care       Date:  2010-07-16       Impact factor: 9.097

View more
  3 in total

1.  Single-Centre Experience of Supra-Renal Vena Cava Resection and Reconstruction.

Authors:  Nikola Vladov; Radoslav Kostadinov; Vassil Mihaylov; Ivelin Takorov; Tsonka Lukanova; Maria Yakova; Tsvetan Trichkov; Evelina Odisseeva; Ventsislav Mutafchiyski
Journal:  World J Surg       Date:  2021-03-16       Impact factor: 3.352

2.  Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database.

Authors:  Ramanathan M Seshadri; Erin H Baker; Megan Templin; Ryan Z Swan; John B Martinie; Dionisios Vrochides; David A Iannitti
Journal:  HPB (Oxford)       Date:  2015-08-14       Impact factor: 3.647

Review 3.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.